4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0000313143-14-000105
President & CEO returned 2,048 shares (to the company)
- President & CEO acquired 26,978 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
CONCANNON BRIAN · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-10-22 | Grant or award : show line 1 in the form | +26,978 | 157,285 | D | ||
| 2014-10-24 | Returned to the company : show line 2 in the form | −2,048 | $35.44 | $72,581 | 155,237 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-10-22 | Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) | +119,731 | $34.75 | 2024-10-22 | 119,731 | 119,731 | D |
| 2014-10-22 | Grant or award : show line 4 in the form Performance Shares | +53,956 | $0.00 | 2017-12-31 | 53,956 | 103,956 | D |
Loading xslF345X03/edgardoc.xml…